JKMS :: Journal of Korean Medical Science
Therapeutic advances in COVID-19 | Nature Reviews Nephrology
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 - ScienceDirect
Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation
HIV protease inhibitors and nuclear lamin processing: Getting the right bells and whistles | PNAS
Biomolecules | Free Full-Text | SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
Paxlovid: Mechanism of Action, Synthesis, and In Silico Study
Research Highlight: Derivatization and Combination Therapy of COVID-19 Therapeutic agents | LAU News
Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data
Epidemic and pandemic viral infections: impact on tuberculosis and the lung | European Respiratory Society
How Ritonavir acts as booster drug - YouTube
Remdesivir and its antiviral activity against COVID-19: A systematic review - Clinical Epidemiology and Global Health
SARS-CoV-2 antivirals ~ ViralZone
A global treatments for coronaviruses including COVID‐19 - Yousefi - 2020 - Journal of Cellular Physiology - Wiley Online Library
Drug repurposing approach to fight COVID-19 | SpringerLink
Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum
Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor‐Dependent Increases in NADPH Oxidase 1 (Nox1), C‐C Chemokine Receptor Type 5 (CCR5), and Inflammation | Journal
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019 | Journal of the American Heart Association
Emerging pharmacotherapies for COVID-19 - ScienceDirect
Review of pharmacologic and immunologic agents in the management of COVID-19 | Biosafety and Health
